Search PDMR transactions

Notifier
Name of person with notification obligation
David Augustsson
Reason for notification
Closely associated
No
Person discharging managerial responsibilities
David Augustsson
Position
Other member of the company's administrative, management or supervisory body
Initial notification
Yes
Amendment
No
Details of amendment
Details of the Issuer/emission allowance market participant/auction platform/auctioneer/auction monitor
Name of issuer
Oncopeptides AB
Issuer´s LEI code
549300J9WWQ5CBYQ1M77
Details of transaction
Type of financial instrument Financial instrument ISIN code Nature of transaction Linked to the exercise of a share option programme Volume Unit Price per unit Currency code Transaction date Place of the transaction
Share Oncopeptides AB SE0009414576 Acquisition 2 Quantity 5.01 SEK 15/04/2024 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 1,250 Quantity 5.05 SEK 15/04/2024 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 60 Quantity 5.06 SEK 15/04/2024 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 1,250 Quantity 5.08 SEK 15/04/2024 NASDAQ STOCKHOLM AB
Share Oncopeptides AB SE0009414576 Acquisition 438 Quantity 5.08 SEK 15/04/2024 NASDAQ STOCKHOLM AB
Aggregation
Financial instrument ISIN code Nature of transaction Transaction date Place of the transaction Volume Weighted average price
Oncopeptides AB SE0009414576 Acquisition 15/04/2024 NASDAQ STOCKHOLM AB 3,000 (Quantity) 5.06705333 SEK
Total: 3,000
<< Back